POLL EXAMINES DRUG SAFETY VIEWS

FEBRUARY 01, 2007

A recent survey of 1726 individuals revealed their perceptions about drug safety.

The poll, which was conducted by Harris Interactive and the Pharmaceutical Safety Institute, found that:

• 52% of respondents felt it is very or highly important to receive safety information on drugs

• 33% of respondents often or always seek drug safety data for themselves, a family member, or someone they provide with care

• 53% of respondents felt that a physician or health care provider is a source they trust to receive more information about the side effects of drugs

• 69% of respondents are confident that the drug companies release information they have about a drug?s adverse reactions as soon as it becomes available




SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.